CIL001 (Paliroden) for diabetes mellitus

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Mar 2026: Trial registered, NCT07472907

The trials

NCT07472907: A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations

State
Not started
Phase
Phase 1 and Phase 2
People
135 planned
Started
Jan 2027
Primary completion
Dec 2027
Arms
CIL001
Results
None posted
  1. 16 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.